
No spam. Unsubscribe anytime.
HPLC Purity Analysis
Adipotide/FTTP
CAS: 62568-57-4
Targeted adipose tissue ablation · Vascular-targeted therapy for energy-balance research · Prohibitin receptor biology
Adipotide is a chimeric peptidomimetic consisting of two functional domains: a targeting motif (CKGGRAKDC) that binds prohibitin on the surface of blood vessels supplying white adipose tissue, and a proapoptotic peptide D(KLAKLAK)2 that disrupts mitochondrial membranes in targeted endothelial cells.
- Targeted adipose tissue ablation
- Vascular-targeted therapy for energy-balance research
- Prohibitin receptor biology
- Proapoptotic peptide mechanisms
This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Frequently Bought Together
Bacteriostatic Water
Required for reconstitution
Semaglutide
GLP-1 / Weight Management
No spam. Unsubscribe anytime.
HPLC Purity Analysis
Specifications
How Adipotide/FTTP Works
Adipotide is a chimeric peptidomimetic consisting of two functional domains: a targeting motif (CKGGRAKDC) that binds prohibitin on the surface of blood vessels supplying white adipose tissue, and a proapoptotic peptide D(KLAKLAK)2 that disrupts mitochondrial membranes in targeted endothelial cells. This triggers apoptosis of the vascular supply to fat tissue, causing adipose tissue regression through ischemia and resorption.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
2mg | $50.00 | $500.00 |
5mg | $110.00 | $1100.00 |
10mgBest Value | $160.00 | $1600.00 |
10-pack pricing shown. Volume discounts for 50+ vials — contact us.
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every order.
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides
Up to 50% OffSemaglutide
Clinically studied for steady weight reduction — once weekly
Up to 60% OffTirzepatide
The most studied dual-agonist for weight reduction
Up to 78% OffRetatrutide
Triple-receptor agonist studied for enhanced metabolic activity
Up to 38% OffLiraglutide
Daily GLP-1 studied for steady appetite regulation